Kenneth B. Kassler Taub Lexicon Pharmaceuticals, Inc. (LXRX) insider trading activity

Kenneth B. Kassler Taub is SVP, Regulatory & QA of LEXICON PHARMACEUTICALS, INC.. Currently has a direct ownership of 162,672 shares of LXRX, which is worth approximately $125,257. The most recent transaction as insider was on Feb 28, 2024, when has been sold 24,353 shares (Common Stock) at a price of $2.62 per share, resulting in proceeds of $63,804. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 163K

0% 3M change

35.98% 12M change

Total Value Held $125,257

Kenneth B. Kassler-Taub Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2024	SELL Payment of exercise price or tax liability	$63,804 $2.62 p/Share	24,353 Reduced 13.02%	162,672 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	-	67,400 Added 26.49%	187,025 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$41,486 $2.17 p/Share	19,118 Reduced 13.78%	119,625 Common Stock
Feb 28 2023	BUY Exercise of conversion of derivative security	-	52,886 Added 27.6%	138,743 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$37,737 $2.85 p/Share	13,241 Reduced 13.36%	85,857 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	-	36,628 Added 26.99%	99,098 Common Stock

KBK

Kenneth B. Kassler Taub

SVP, Regulatory & QA

The Woodlands, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXRX shares.

Notify only if

Value

Insider Trading

Get notified when an Lexicon Pharmaceuticals, Inc. insider buys or sells LXRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to LEXICON PHARMACEUTICALS, INC.

Track Activities on LXRX

Account